65 VII, invitro diagnostics, reagents, test kits, & test sets, FSS contract award
Active Awarded Last action
- Contract number
- 36F79726D0099
- Awardee
-
Roche Diabetes Care Inc. UEI F6JDDN8L9JM4
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- M5Q52A0406 Solicitation number
- Last date to order 11% complete
- IDV ceiling
- $1,668,444,470.00
- Maximum order
- $25,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Roche Diabetes Care Inc. under the In-Vitro Diagnostics, Reagents, Test Kits & Test Sets schedule (FSS-65-VII) on April 1, 2026, with an evergreen modification and a ceiling value of $1.668 billion through March 31, 2031.
Roche Diabetes Care Inc., headquartered in Indianapolis, Indiana, manufactures and distributes blood glucose monitors, test strips, lancets, control solutions, and in-vitro diagnostic reagents to federal healthcare organizations. The company is registered in SAM.gov and has been a federal supplier since May 14, 2015.
Performance occurs nationwide across federal agency facilities. The Indian Health Service has been the primary customer, awarding delivery orders and blanket purchase agreement calls to support diabetes management programs for American Indian and Alaska Native populations across IHS-operated medical centers, including the Phoenix Indian Medical Center. The Department of Justice Bureau of Prisons has also consistently ordered laboratory reagents and diagnostic test materials for inmate healthcare services, with performance at the Castleton, Indiana location. Individual delivery order values have ranged from approximately $10,000 to $750,000.
Roche currently operates two active blanket purchase agreements under the GSA schedule: a $2 million BPA awarded by IHS on September 23, 2021 (extending through September 26, 2026) and a $1.660 million BPA awarded by IHS on May 25, 2023 (extending through May 14, 2026). Both BPAs enable efficient procurement of diabetic testing supplies and meters on an as-needed basis at GSA schedule pricing rates.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79726D0099?
36F79726D0099 was awarded to Roche Diabetes Care Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2026.
How much is contract 36F79726D0099 worth?
36F79726D0099's own ceiling is $1,668,444,470. A single order can be worth up to $25,000.
Who can order from contract 36F79726D0099?
36F79726D0099 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79726D0099 part of a contract vehicle?
Yes. 36F79726D0099 is part of Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36F79726D0099 competed?
The extent of competition for 36F79726D0099 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV